Victory Capital Management Inc Soleno Therapeutics Inc Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.14 - $0.23 $1,874 - $3,079	-13,387 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.22 - $0.47 $2,945 - $6,291	13,387 New	13,387 $3,000
Q2 2020 Aug 07, 2020	SELL	$1.77 - $4.23 $10,126 - $24,199	-5,721 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$1.64 - $3.85 $170 - $400	104 Added 1.85%	5,721 $14,000
Q4 2019 Feb 04, 2020	BUY	$1.35 - $2.95 $4,099 - $8,959	3,037 Added 117.71%	5,617 $19,000
Q3 2019 Nov 12, 2019	BUY	$1.5 - $2.99 $3,870 - $7,714	2,580 New	2,580 $4,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.